It has been shown that monocytes in patients with MPN abnormally express CD56 and have an increase in intermediate and non-classical monocytes [21], furthermore, granulocytes in patients with PMF also show abnormal features such as an abnormal CD13/CD16 phenotype and expression of CD56 [22]. This evidence concerns the gene NCAM1 and myeloproliferative neoplasm.